Filing Details

Accession Number:
0001225208-21-010900
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-27 20:28:39
Reporting Period:
2021-07-27
Accepted Time:
2021-07-27 20:28:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1484186 Michael Joseph Fitzgerald 300 Boston Scientific Way
Marlborough MA 01752-1234
Evp & Pres, Interven Cardio No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-06 12,000 $0.00 238,780 No 5 G Direct
Common Stock Acquisiton 2021-07-27 70,306 $6.28 309,086 No 4 M Direct
Common Stock Disposition 2021-07-27 105,490 $45.00 203,596 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-07-27 70,306 $0.00 70,306 $6.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-02-27 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 68,258 Indirect By 401(k)
Common Stock 6,038 Indirect By Children
Footnotes
  1. This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
  2. Represents the weighted average sale price. These shares were sold in multiple transactions at $45.00 and $45.02. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
  4. The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose.
  5. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.